Thymosin alpha 1 does not promote growth or oncogenic transformation. 1996

P H Naylor, and M R Smith, and M G Mutchnick, and C W Naylor, and J Dosescu, and M Skunca, and J A Moshier
Department of Internal Medicine, Wayne State University, School of Medicine, Detroit, MI 48201, USA.

Thymosin alpha 1 (T alpha 1) is an immune modulatory peptide which has been evaluated in a variety of clinical trials. Although no in vivo adverse effects, including enhancement of tumor growth, have been noted, in vitro studies suggesting a role for T alpha 1 in cell growth have been reported. The studies presented in this report evaluated both exogenously added T alpha 1 and endogenously expressed T alpha 1 as factors which could either promote growth of tumor cells or induce transformation. No effect of exogenous T alpha 1 on cell growth was found. NIH-3T3 cells transfected with cDNA for the precursor ProThymosin alpha (Pro T alpha) expressed elevated levels of authentic T alpha 1 but did not demonstrate either enhanced proliferation in liquid culture or transformation as defined by the loss of contact inhibition or anchorage independent growth in soft agar. Thus these studies argue against the hypothesis that T alpha 1 is either an intracellular or extracellular growth promoter.

UI MeSH Term Description Entries
D007078 Ileal Neoplasms Tumors or cancer in the ILEUM region of the small intestine (INTESTINE, SMALL). Cancer of ILEUM,Cancer of the ILEUM,Cancer, Ileal,Ileal Cancer,Cancers, Ileal,ILEUM Cancer,ILEUM Cancers,Ileal Cancers,Ileal Neoplasm,Neoplasm, Ileal,Neoplasms, Ileal
D011498 Protein Precursors Precursors, Protein
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D002430 Cecal Neoplasms Tumors or cancer of the CECUM. Cancer of Cecum,Cecal Cancer,Cancer of the Cecum,Cancer, Cecal,Neoplasms, Cecal,Cecal Neoplasm,Neoplasm, Cecal
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D002471 Cell Transformation, Neoplastic Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill. Neoplastic Transformation, Cell,Neoplastic Cell Transformation,Transformation, Neoplastic Cell,Tumorigenic Transformation,Cell Neoplastic Transformation,Cell Neoplastic Transformations,Cell Transformations, Neoplastic,Neoplastic Cell Transformations,Neoplastic Transformations, Cell,Transformation, Cell Neoplastic,Transformation, Tumorigenic,Transformations, Cell Neoplastic,Transformations, Neoplastic Cell,Transformations, Tumorigenic,Tumorigenic Transformations
D003110 Colonic Neoplasms Tumors or cancer of the COLON. Cancer of Colon,Colon Adenocarcinoma,Colon Cancer,Cancer of the Colon,Colon Neoplasms,Colonic Cancer,Neoplasms, Colonic,Adenocarcinoma, Colon,Adenocarcinomas, Colon,Cancer, Colon,Cancer, Colonic,Cancers, Colon,Cancers, Colonic,Colon Adenocarcinomas,Colon Cancers,Colon Neoplasm,Colonic Cancers,Colonic Neoplasm,Neoplasm, Colon,Neoplasm, Colonic,Neoplasms, Colon
D006133 Growth Substances Signal molecules that are involved in the control of cell growth and differentiation. Mitogens, Endogenous,Endogenous Mitogens
D000230 Adenocarcinoma A malignant epithelial tumor with a glandular organization. Adenocarcinoma, Basal Cell,Adenocarcinoma, Granular Cell,Adenocarcinoma, Oxyphilic,Adenocarcinoma, Tubular,Adenoma, Malignant,Carcinoma, Cribriform,Carcinoma, Granular Cell,Carcinoma, Tubular,Adenocarcinomas,Adenocarcinomas, Basal Cell,Adenocarcinomas, Granular Cell,Adenocarcinomas, Oxyphilic,Adenocarcinomas, Tubular,Adenomas, Malignant,Basal Cell Adenocarcinoma,Basal Cell Adenocarcinomas,Carcinomas, Cribriform,Carcinomas, Granular Cell,Carcinomas, Tubular,Cribriform Carcinoma,Cribriform Carcinomas,Granular Cell Adenocarcinoma,Granular Cell Adenocarcinomas,Granular Cell Carcinoma,Granular Cell Carcinomas,Malignant Adenoma,Malignant Adenomas,Oxyphilic Adenocarcinoma,Oxyphilic Adenocarcinomas,Tubular Adenocarcinoma,Tubular Adenocarcinomas,Tubular Carcinoma,Tubular Carcinomas
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

P H Naylor, and M R Smith, and M G Mutchnick, and C W Naylor, and J Dosescu, and M Skunca, and J A Moshier
July 2019, Scientific reports,
P H Naylor, and M R Smith, and M G Mutchnick, and C W Naylor, and J Dosescu, and M Skunca, and J A Moshier
October 2011, BMC cancer,
P H Naylor, and M R Smith, and M G Mutchnick, and C W Naylor, and J Dosescu, and M Skunca, and J A Moshier
May 2001, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists,
P H Naylor, and M R Smith, and M G Mutchnick, and C W Naylor, and J Dosescu, and M Skunca, and J A Moshier
December 1996, Journal of hepatology,
P H Naylor, and M R Smith, and M G Mutchnick, and C W Naylor, and J Dosescu, and M Skunca, and J A Moshier
January 1982, Journal of immunology (Baltimore, Md. : 1950),
P H Naylor, and M R Smith, and M G Mutchnick, and C W Naylor, and J Dosescu, and M Skunca, and J A Moshier
December 1983, Proceedings of the National Academy of Sciences of the United States of America,
P H Naylor, and M R Smith, and M G Mutchnick, and C W Naylor, and J Dosescu, and M Skunca, and J A Moshier
January 1985, Methods in enzymology,
P H Naylor, and M R Smith, and M G Mutchnick, and C W Naylor, and J Dosescu, and M Skunca, and J A Moshier
June 2000, Annals of the New York Academy of Sciences,
P H Naylor, and M R Smith, and M G Mutchnick, and C W Naylor, and J Dosescu, and M Skunca, and J A Moshier
January 1993, Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy,
P H Naylor, and M R Smith, and M G Mutchnick, and C W Naylor, and J Dosescu, and M Skunca, and J A Moshier
May 1980, The New England journal of medicine,
Copied contents to your clipboard!